Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Deletion of Tmtc4 activates the unfolded protein response and causes postnatal hearing loss
Jiang Li, Omar Akil, Stephanie L. Rouse, Conor W. McLaughlin, Ian R. Matthews, Lawrence R. Lustig, Dylan K. Chan, Elliott H. Sherr
Jiang Li, Omar Akil, Stephanie L. Rouse, Conor W. McLaughlin, Ian R. Matthews, Lawrence R. Lustig, Dylan K. Chan, Elliott H. Sherr
View: Text | PDF
Research Article Cell biology Otology

Deletion of Tmtc4 activates the unfolded protein response and causes postnatal hearing loss

  • Text
  • PDF
Abstract

Hearing loss is a significant public health concern, affecting over 250 million people worldwide. Both genetic and environmental etiologies are linked to hearing loss, but in many cases the underlying cellular pathophysiology is not well understood, highlighting the importance of further discovery. We found that inactivation of the gene Tmtc4 (transmembrane and tetratricopeptide repeat 4), which was broadly expressed in the mouse cochlea, caused acquired hearing loss in mice. Our data showed Tmtc4 enriched in the endoplasmic reticulum, and that it functioned by regulating Ca2+ dynamics and the unfolded protein response (UPR). Given this genetic linkage of the UPR to hearing loss, we demonstrated a direct link between the more common noise-induced hearing loss (NIHL) and the UPR. These experiments suggested a novel approach to treatment. We demonstrated that the small-molecule UPR and stress response modulator ISRIB (integrated stress response inhibitor), which activates eIF2B, prevented NIHL in a mouse model. Moreover, in an inverse genetic complementation approach, we demonstrated that mice with homozygous inactivation of both Tmtc4 and Chop had less hearing loss than knockout of Tmtc4 alone. This study implicated a novel mechanism for hearing impairment, highlighting a potential treatment approach for a broad range of human hearing loss disorders.

Authors

Jiang Li, Omar Akil, Stephanie L. Rouse, Conor W. McLaughlin, Ian R. Matthews, Lawrence R. Lustig, Dylan K. Chan, Elliott H. Sherr

×

Figure 6

Ca2+ dynamics in cochlear supporting cells.

Options: View larger image (or click on image) Download as PowerPoint
Ca2+ dynamics in cochlear supporting cells.
Ratiometric FURA-2 imaging w...
Ratiometric FURA-2 imaging was used to measure cytosolic [Ca2+]i in WT and Tmtc4-KO P3–P5 cochlear cultures. (A) Representative spontaneous intracellular Ca2+ wave in the inner sulcus of the organ of Corti. Regions of interest (7-μm square) in the inner and outer sulci were identified and FURA-2 excitation ratios (proportional to cytosolic Ca2+ concentration) measured. Ca2+ peaks were extracted and analyzed. (B) Aggregate ratio time course for Ca2+ peaks normalized to baseline and peak maximum show identical initial kinetics and faster return to baseline in WT cochleae treated with the SERCA2B activator CDN1163 (CDN) plus the SERCA2B inhibitor thapsigargin (TG) (n = 88 peaks) compared with TG (n = 65 peaks) alone, demonstrating the ability of known modulators of ER Ca2+ reuptake to affect Ca2+ peak decay time. (C–E) Analysis of 273 and 653 peaks, respectively, from 6 WT and 6 KO cochleae. (C) Peaks in Tmtc4-KO cochleae (n = 653) showed prolongation of return to baseline cytosolic Ca2+ level relative to WT controls (n = 273). (B and C) Black bars: points at which aggregate ratios were statistically significantly different. Peak frequency (D) (mean ± SEM) and height (E) (mean ± SEM) were greater in KO cochleae. (F) Decay time in WT cochleae was measured in dissecting solution (DS) and with drugs (CDN: 10 μM CDN1163; TG: 1 μM TG; and TG+CDN: 10 μM CDN1163 and 1 μM TG) as well as for Tmtc4-KO cochleae in DS. Data indicate difference in mean ± SE of decay time relative to that measured in WT cochleae in DS (number of peaks analyzed for each comparison in parentheses).*P < 0.01 for DS in WT cochleae. #P < 0.0001 versus TG in WT cochleae (unpaired, 2-tailed t test for all comparisons).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts